Items where authors include "Ishak, M."

Article

Agarwal, S. orcid.org/0000-0002-2350-4610, Huang, X. orcid.org/0000-0001-8156-0330, Sheu, W. orcid.org/0000-0003-1889-0227 et al. (49 more authors) (2026) DESI strong lens foundry. III. Keck spectroscopy for strong lenses discovered using residual neural networks. The Astrophysical Journal, 1001 (2). 162. ISSN 0004-637X

Amsellem, A.J. orcid.org/0000-0003-3433-2698, Palmese, A. orcid.org/0000-0002-6011-0530, Douglass, K. orcid.org/0000-0002-9540-546X et al. (55 more authors) (2026) Probing the environment around GW170817 with DESI: Insights on galaxy group peculiar velocities for standard siren measurements. The Astrophysical Journal, 1001 (2). 157. ISSN 0004-637X

Abdul Karim, M. orcid.org/0009-0000-7133-142X, Adame, A.G., Aguado, D. orcid.org/0000-0001-5200-3973 et al. (306 more authors) (2026) Data Release 1 of the Dark Energy Spectroscopic Instrument. The Astronomical Journal, 171 (5). 285. ISSN 0004-6256

Abani, O., Abbas, A., Abbas, F. et al. (7724 more authors) (2026) Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases, 26 (1). pp. 34-45. ISSN 1473-3099

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Feng, J.L. orcid.org/0000-0002-7713-2138, Kling, F. orcid.org/0000-0002-3100-6144, Reno, M.H. orcid.org/0000-0001-6264-3990 et al. (396 more authors) (2023) The forward physics facility at the high-luminosity LHC. Journal of Physics G: Nuclear and Particle Physics, 50 (3). 030501. ISSN 0954-3899